2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Zusammenfassung

2019 ESC/EAS Guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Authors/Task Force Members: Franc ̧ois Mach* (Chairperson) (Switzerland), Colin Baigent* (Chairperson) (United Kingdom), Alberico L. Catapano 1 * (Chairperson) (Italy), Konstantinos C. Koskinas (Switzerland), Manuela Casula 1 (Italy), Lina Badimon (

Kerninformationen

es document reviewers and Author/Task Force Member affiliations: listed in the Appendix. 1 Representing the EAS. ESC entities having participated in the development of this document: Associations:Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing & Allied Professions...

professionals are encouraged to take the ESC/EAS Guidelines fully into account when exercising their clinical judgment, as wellas in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC/EAS Guidelines do not override, in any way what...

lberto Corsini 1 (Italy), Wolfram Doehner (Germany), Michel Farnier (France), Bruna Gigante (Sweden), Meral Kayikcioglu 1 (Turkey), Goran Krstacic (Croatia), Ekaterini Lambrinou (Cyprus), Basil S. Lewis (Israel), Josep Masip (Spain), Philippe Moulin 1 (France), Steffen Petersen (United Kingdom), Ann...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen